Brouwers, P., Bouquegneau, A., & Cavalier, E. (2024). Insight into the potential of bone turnover biomarkers: integration in the management of osteoporosis and chronic kidney disease-associated osteoporosis. Current Opinion in Endocrinology, Diabetes, and Obesity. doi:10.1097/MED.0000000000000869 |
Massonnet, P., Farre Segura, J., Cobraiville, G., Fillet, M., Servais, A.-C., LUKAS, P., GENDEBIEN, A.-S., Peeters, S., Le Goff, C., Bouquegneau, A., Jean-Claude Souberbielle, Vincent Delatour, Delanaye, P., & Cavalier, E. (09 April 2024). Quantification of 1-84 Parathyroid Hormone: from immunoassays to LC-MS/MS candidate reference measurement [Paper presentation]. Analytica 2024, Munich, Germany. |
Raynaud, M., Al-Awadhi, S., Louis, K., Zhang, H., Su, X., Goutaudier, V., Wang, J., Demir, Z., Wei, Y., Truchot, A., Bouquegneau, A., Del Bello, A., Bailly, É., Lombardi, Y., Maanaoui, M., Giarraputo, A., Naser, S., Divard, G., Aubert, O., ... Loupy, A. (2023). Prognostic Biomarkers in Kidney Transplantation: a Systematic Review and Critical Appraisal. Journal of the American Society of Nephrology. doi:10.1681/ASN.0000000000000260 |
Bouquegneau, A., Mina, M., GERARD, C., Rinkin, C., Seidel, L., Ribbens, C., & Malaise, O. (2023). Le TBS (Trabecular Bone Score) peut-il prédire la microarchitecture osseuse observée par microscanner osseux périphérique dans deux populations d’ostéoporose secondaire ? Revue du Rhumatisme. |
Cavalier, E., Farre Segura, J., LUKAS, P., GENDEBIEN, A.-S., Peeters, S., Massonnet, P., Le Goff, C., Bouquegneau, A., Souberbielle, J.-C., Delatour, V., & Delanaye, P. (2023). Unveiling a new era with liquid chromatography coupled with mass spectrometry to enhance parathyroid hormone measurement in patients with chronic kidney disease. Kidney International. doi:10.1016/j.kint.2023.09.033 |
Malaise, O., Bouquegneau, A., Seidel, L., GERARD, C., Rinkin, C., & Ribbens, C. (September 2023). Can “Trabecular Bone Score” predict bone micro-architecture in patients with rheumatoid arthritis or chronic kidney disease ? [Paper presentation]. Belgian Congress of Rheumatology. |
Fank, H.* , Weekers, L.* , Lovinfosse, P.* , Pottel, H., Seidel, L., Jadoul, A., Bouquegneau, A., BONVOISIN, C., Bovy, C., GROSCH, S., Erpicum, P., Hustinx, R., & Jouret, F. (25 August 2023). The uptake of [18F]-fluorodeoxyglucose by the renal allograft correlates with the acute Banff scores of cortex inflammation but not with the 1-year graft outcomes. Frontiers in Transplantation, 2. doi:10.3389/frtra.2023.1236751 * These authors have contributed equally to this work. |
Masson, G., Viva, T., Huart, J., Weekers, L., BONVOISIN, C., Bouquegneau, A., MAWEJA, S., Hamoir, E., Seidel, L., Pottel, H., Lancellotti, P., & Jouret, F. (01 August 2023). The Effect of Elective Ligation of the Arteriovenous Fistula on Cardiac and Renal Functions in Kidney Transplant Recipients. Kidney360, 4 (8), 1130 - 1138. doi:10.34067/KID.0000000000000198 |
Mariat, C., Gaillard, F., Fournier, T., Rabate, C., Pincon, É., Bacchetta, J., Aurelle, M., & Bouquegneau, A. (26 April 2023). Pourquoi développer la greffe de rein à partir de donneurs vivants en France en 2023 ? Néphrologie et Thérapeutique, 19 (2), 83 - 88. doi:10.1684/ndt.2023.20 |
Erpicum, P., Pinto Coelho, T., BONVOISIN, C., Bouquegneau, A., GROSCH, S., Navez, M., Vandermeulen, M., Beguin, Y., Detry, O., Jouret, F., & WEEKERS, L. (February 2023). Reprise retardée de fonction du greffon après transplantation rénale : un challenge clinique toujours d’actualité. Revue Médicale de Liège, 78 (2), 107 - 113. |
Al-Awadhi, S., Raynaud, M., Louis, K., Bouquegneau, A., Taupin, J.-L., Aubert, O., Loupy, A., & Lefaucheur, C. (2023). Complement-activating donor-specific anti-HLA antibodies in solid organ transplantation: systematic review, meta-analysis, and critical appraisal. Frontiers in Immunology, 14, 1265796. doi:10.3389/fimmu.2023.1265796 |
Ancion, A., Poirrier, A.-L., Dessard Laura, Detrembleur, N., Bouquegneau, A., Lepage Pierre, Duran, U., Reuter, G., Lefèbvre, P., & Rogister, F. (2023). Rhino-Sinusal Mucormycosis: About the Management of 2 Clinical Cases. B-ENT. doi:10.5152/B-ENT.2023.22942 |
Delanaye, P., Lanot, A., Bouquegneau, A., Warling, X., Radermacher, L., Masset, C., Krzesinski, J.-M., Moranne, O., & Cavalier, E. (January 2023). Monitoring 25-OH and 1,25-OH vitamin D levels in hemodialysis patients after starting therapy: Does it make sense? Clinica Chimica Acta, 539, 50-54. doi:10.1016/j.cca.2022.11.032 |
TIV, H., Vandelaer, A., Delanaye, P., Forte, F., & Bouquegneau, A. (December 2022). Piège diagnostique : neurotoxicité au lithium avec lithémie normale. Néphrologie et Thérapeutique, 18 (7), 650 - 654. doi:10.1016/j.nephro.2022.07.398 |
Donker, E. M., Bet, P., Nurmohamed, A., Serné, E., Burchell, G. L., Friedman, A. N., Bouquegneau, A., Lemoine, S., Ebert, N., Cirillo, M., van Agtmael, M. A., & Bartelink, I. H. (September 2022). Estimation of glomerular filtration rate for drug dosing in patients with very high or low body mass index. Clinical and Translational Science, 15 (9), 2206 - 2217. doi:10.1111/cts.13354 |
Firket, L., Bouquegneau, A., Seidel, L., BONVOISIN, C., GROSCH, S., Hayette, M.-P., Jouret, F., & WEEKERS, L. (2022). The prospective screening for SARS-CoV-2 S1/S2 antibodies delineates the factual incidence of COVID-19 and shows a sustained serological response <i>post</i> COVID-19 in kidney transplant recipients. Acta Clinica Belgica, 1-6. doi:10.1080/17843286.2022.2108978 |
BOUQUEGNEAU, A., MALAISE, O., SEIDEL, L., BONVOISIN, C., WEEKERS, L., JOURET, F., CAVALIER, E., & DELANAYE, P. (May 2022). Bone Mineral Density, Bone Micro-Architecture Evolution After Kidney Transplantation: A Prospective Cohort Study. Nephrology Dialysis Transplantation, 37 (Supplement_3). doi:10.1093/ndt/gfac073.006 |
ERPICUM, P., BONVOISIN, C., GROSCH, S., BOVY, C., Pinto Coelho, T., DETRY, O., JOURET, F., WEEKERS, L., & BOUQUEGNEAU, A. (May 2022). Diagnostic et prise en charge thérapeutique du rejet en transplantation rénale. Revue Médicale de Liège, 77 (5-6), 338-344. |
GROSCH, S., ERPICUM, P., BOUQUEGNEAU, A., JOURET, F., & BOVY, C. (May 2022). Le glomérule dans tous ses états. Revue Médicale de Liège, 77 (5-6), 330-337. |
DELANAYE, P., Cavalier, E., & Bouquegneau, A. (2022). The ideal drug dosage adaptation through estimated glomerular filtration rate in obese patients? Measuring GFR is the key. British Journal of Clinical Pharmacology. doi:10.1111/bcp.15255 |
DELANAYE, P., Gaillard, F., van der Weijden, J., Mjøen, G., Ferhman-Ekholm, I., Dubourg, L., Ebert, N., Schaeffner, E., Åkerfeldt, T., Goffin, K., Couzi, L., Garrouste, C., Rostaing, L., Courbebaisse, M., Legendre, C., Hourmant, M., Kamar, N., Cavalier, E., WEEKERS, L., ... van Londen, M. (2022). Age-adapted percentiles of measured glomerular filtration in healthy individuals: extrapolation to living kidney donors over 65 years. Clinical Chemistry and Laboratory Medicine, 60 (3), 401-407. doi:10.1515/cclm-2021-1011 |
Erpicum, P., Grosch, S., Bonvoisin, C., Bouquegneau, A., Weekers, L., Radermacher, L., Jouret, F., LEJEUNE, M., Hougrand, O., & Bovy, C. (2022). The Case | An unusual cause of renal vascular thrombi after kidney transplantation. Kidney International, 101 (2), 427-428. doi:10.1016/j.kint.2021.08.008 |
MALAISE, O., SEIDEL, L., BONVOISIN, C., WEEKERS, L., JOURET, F., MALAISE, M., CAVALIER, E., DELANAYE, P., & BOUQUEGNEAU, A. (2022). BONE MINERAL DENSITY AND BONE MICRO-ARCHITECTURE EVOLUTION AFTER KIDNEY TRANSPLANTATION: 3-MONTHS RESULTS OF A PROSPECTIVE COHORT STUDY. Osteoporosis International. |
Firket, L., Descy, J., Seidel, L., Bonvoisin, C., Bouquegneau, A., Grosch, S., Jouret, F., & Weekers, L. (November 2021). Serological response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients depends on prior exposure to SARS-CoV-2. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 21 (11), 3806-3807. doi:10.1111/ajt.16726 |
Nakanishi, T., Pigazzini, S., Degenhardt, F., Cordioli, M., Butler-Laporte, G., Maya-Miles, D., Nafría-Jiménez, B., Bouysran, Y., Niemi, M., Palom, A., Ellinghaus, D., Khan, A., Martínez-Bueno, M., Rolker, S., Amitano, S., Tato, L. R., Fava, F., Spinner, C. D., Prati, D., ... consortium, C.-H. (October 2021). Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality. Journal of Clinical Investigation, Online ahead of print.. doi:10.1172/JCI152386 |
BOUQUEGNEAU, A., ERPICUM, P., GROSCH, S., HABRAN, L., HOUGRAND, O., HUART, J., KRZESINSKI, J.-M., Misset, B., Hayette, M.-P., DELVENNE, P., BOVY, C., Kylies, D., huber, T. B., Puelles, V. G., DELANAYE, P., & Jouret, F. (2021). COVID-19-associated nephropathy includes tubular necrosis and capillarycongestion, with evidence of SARS-CoV-2 in the nephron. Kidney International. doi:10.34067/KID.0006992020 |
HUART, J., BOUQUEGNEAU, A., Lutteri, L., ERPICUM, P., GROSCH, S., Résimont, G., WIESEN, P., BOVY, C., Krzesinski, J.-M., THYS, M., LAMBERMONT, B., Misset, B., Pottel, H., Mariat, C., CAVALIER, E., Burtey, S., Jouret, F., & DELANAYE, P. (23 January 2021). Proteinuria in COVID‑19: prevalence, characterization and prognostic role. Journal of Nephrology, 34 (3), 355-364. doi:10.1007/s40620-020-00931-w |
BOUQUEGNEAU, A., HUART, J., LUTTERI, L., ERPICUM, P., GROSCH, S., Résimont, G., WIESEN, P., ROUSSEAU, A.-F., BOVY, C., KRZESINSKI, J.-M., THYS, M., LAMBERMONT, B., Misset, B., Pottel, H., DARCIS, G., CAVALIER, E., JOURET, F., & DELANAYE, P. (2021). Survivors of COVID-19 mostly recover from tubular proteinuria and acute kidney injury after hospital discharge. Journal of Nephrology, 34 (4), 967-969. doi:10.1007/s40620-021-01075-1 |
Darcis, G., Bouquegneau, A., Maes, N., Thys, M., Henket, M., Labye, F., Rousseau, A.-F., Canivet, P., Desir, C., Calmes, D., Schils, R., De Worm, S., Léonard, P., Meunier, P., Moutschen, M., Louis, R., & Guiot, J. (2021). Long-term clinical follow-up of patients suffering from moderate-to-severe COVID-19 infection: a monocentric prospective observational cohort study. International Journal of Infectious Diseases, 109, 209-216. doi:10.1016/j.ijid.2021.07.016 |
DELANAYE, P., HUART, J., BOUQUEGNEAU, A., & JOURET, F. (2021). Long-term effects of COVID-19 on kidney function [letter to the editor]. The Lancet, 397 (10287), 1807. doi:10.1016/S0140-6736(21)00881-3 |
LOVINFOSSE, P., Weekers, F., Pottel, H., BOUQUEGNEAU, A., BONVOISIN, C., BOVY, C., GROSCH, S., Hustinx, R., & Jouret, F. (2021). [(18)F]FDG PET/CT imaging disproves renal allograft acute rejection in kidney transplant recipients with acute kidney dysfunction: a validation cohort. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-021-05467-0 |
Maisons, V., Garnier, A.-S., Lohéac, C., Bouquegneau, A., Goubella, A., Hocine, A., & Bobot, M. (2021). Letter Regarding "Impact of the COVID-19 Pandemic on Training and Well-Being of Nephrology Residents in France and Belgium". Kidney International Reports. doi:10.1016/j.ekir.2021.12.035 |
Reese, P. P., Aubert, O., Naesens, M., Huang, E., Potluri, V., Kuypers, D., Bouquegneau, A., Divard, G., Raynaud, M., Bouatou, Y., Vo, A., Glotz, D., Legendre, C., Lefaucheur, C., Jordan, S., Empana, J.-P., Jouven, X., & Loupy, A. (2021). Assessment of the Utility of Kidney Histology as a Basis for Discarding Organs in the United States: A Comparison of International Transplant Practices and Outcomes. Journal of the American Society of Nephrology : JASN, 32 (2), 397-409. doi:10.1681/ASN.2020040464 |
DELANAYE, P., BOUQUEGNEAU, A., Moranne, O., & Cavalier, E. (2020). Comment estimer la filtration glomérulaire dans le contexte de l’adaptation posologique de médicaments ? Revue Médicale Suisse, 16 (703), 1489-1493. |
ERPICUM, P., GROSCH, S., BOUQUEGNEAU, A., HUART, J., Résimont, G., BOVY, C., HABRAN, L., Delvenne, P., KRZESINSKI, J.-M., BURTEY, S., DELANAYE, P., & Jouret, F. (2020). Atteintes rénales de la COVID-19. Revue Médicale de Liège. Supplément, 75 (supplément 1), 109-S114. |
JADOUL, A.* , LOVINFOSSE, P.* , BOUQUEGNEAU, A., WEEKERS, L., Pottel, H., Hustinx, R., & Jouret, F. (2020). Observer variability in the assessment of renal (18)F-FDG uptake in kidney transplant recipients. Scientific Reports, 10 (1), 4617. doi:10.1038/s41598-020-61032-z * These authors have contributed equally to this work. |
BOUQUEGNEAU, A., Evenepoel, P., PAQUOT, F., MALAISE, O., CAVALIER, E., & DELANAYE, P. (2019). Sclerostin within the chronic kidney disease spectrum. Clinica Chimica Acta, 502, 84-90. doi:10.1016/j.cca.2019.12.008 |
Hanssen, O., Weekers, L., Lovinfosse, P., Jadoul, A., Bonvoisin, C., Bouquegneau, A., Grosch, S., Huynen, A., Anglicheau, D., Hustinx, R., & Jouret, F. (2019). Diagnostic yield of (18) F-FDG PET/CT imaging and urinary CXCL9/creatinine levels in kidney allograft subclinical rejection. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. doi:10.1111/ajt.15742 |
Loupy, A., Bouquegneau, A., Stegall, M. D., & Montgomery, R. A. (2019). Clinical outcomes after ABO-incompatible renal transplantation. Lancet (London, England), 394 (10213), 1988-1989. doi:10.1016/S0140-6736(19)32490-0 |
BOUQUEGNEAU, A., Loheac, C., Aubert, O., Bouatou, Y., Viglietti, D., Empana, J. P., Ulloa, C., Hassan Murad, M., Legendre, C., Glotz, D., Jackson, A. M., Zeevi, A., Schaub, S., Taupin, J. L., Reed, E. F., Friedewald, J. J., Tyan, D. B., Süsal, C., Shapiro, R., ... Loupy, A. (2018). Complement-activating donor-specific anti-HLA antibodies and solid organ transplant survival: A systematic review and meta-analysis. PLoS Medicine, 15 (5). doi:10.1371/journal.pmed.1002572 |
DELANAYE, P., PAQUOT, F., BOUQUEGNEAU, A., Blocki, F., Krzesinski, J.-M., Evenepoel, P., Pottel, H., & Cavalier, E. (2018). Sclerostin and chronic kidney disease: the assay impacts what we (thought to) know. Nephrology Dialysis Transplantation, 33 (8), 1404-1410. doi:10.1093/ndt/gfx282 |
DELANAYE, P., Guerber, F., SCHEEN, A., Ellam, T., BOUQUEGNEAU, A., Guergour, D., Mariat, C., & Pottel, H. (February 2017). Discrepancies between the Cockcroft–Gault and Chronic Kidney Disease Epidemiology (CKD-EPI) Equations: Implications for Refining Drug Dosage Adjustment Strategies. Clinical Pharmacokinetics, 56 (2), 193-205. doi:10.1007/s40262-016-0434-z |
DELANAYE, P., BOUQUEGNEAU, A., DUBOIS, B., SPRYNGER, M., Mariat, C., KRZESINSKI, J.-M., & Lancellotti, P. (2017). Fibrillation auriculaire et anticoagulation chez le patient hémodialysé : une décision difficile. Néphrologie et Thérapeutique. doi:10.1016/j.nephro.2016.09.002 |
JADOT, V., Krzesinski, J.-M., VON FRENCKELL, C., BOVY, C., & BOUQUEGNEAU, A. (2017). La néphropathie lupique : les nouvelles perspectives de traitement. Néphrologie et Thérapeutique, 14, 1-12. doi:10.1016/j.nephro.2017.05.002 |
Denis, C., JADOT, V., BOUQUEGNEAU, A., & Krzesinski, J.-M. (September 2016). The Case : Acute renal failure and refractory hyponatremia. Kidney International, 90, 713-714. doi:10.1016/j.kint.2016.02.038 |
BOUQUEGNEAU, A., Salam, S., DELANAYE, P., Eastell, R., & Khwaja, A. (2016). Bone disease after kidney transplantation. Clinical Journal of the American Society of Nephrology, 11 (7), 1282-1296. doi:10.2215/CJN.11371015 |
BOUQUEGNEAU, A., Vidal-Petiot, E., Moranne, O., Mariat, C., Boffa, J., Vrtovsnik, F., SCHEEN, A., KRZESINSKI, J.-M., Flamant, M., & DELANAYE, P. (2016). Creatinine-based equations for the adjustment of drug dosage in an obese population. British Journal of Clinical Pharmacology, 81 (2), 349-361. doi:10.1111/bcp.12817 |
PAQUOT, F., BOUQUEGNEAU, A., CAVALIER, E., & DELANAYE, P. (2016). Sclérostine & insuffisance rénale: que nous apprennent les différents méthodes de dosage? Néphrologie et Thérapeutique, 12 (5), 374. |
DELANAYE, P., CAVALIER, E., BOUQUEGNEAU, A., & Khwaja, A. (December 2015). Sclerostin levels in CKD patients : an important, but not definitive, step on the way to clinical use. Kidney International, 88 (6), 1221-1223. doi:10.1038/ki.2015.258 |
DELANAYE, P., Liabeuf, S., BOUQUEGNEAU, A., CAVALIER, E., & Massy, Z. (July 2015). L'éveil de la matrix-gla-protéine sonnera le glas des calcifications vasculaires. Néphrologie et Thérapeutique, 11 (4), 191-200. doi:10.1016/j.nephro.2014.12.003 |
BOUQUEGNEAU, A., KRZESINSKI, J.-M., DELANAYE, P., & CAVALIER, E. (30 March 2015). Biomarkers and physiolpathology in the cardiorenal syndrome. Clinica Chimica Acta, 443, 100-107. |
DELANAYE, P., BOUQUEGNEAU, A., KRZESINSKI, J.-M., CAVALIER, E., Jean, G., Urena-Torres, P., & Souberbielle, J.-C. (February 2015). Place de la vitamine D native en dialyse. Néphrologie et Thérapeutique, 11 (1), 5-15. doi:10.1016/j.nephro.2014.10.004 |
BOUQUEGNEAU, A., Vidal-Petiot, E., Vrtovsnik, F., Moranne, O., Flamant, M., & DELANAYE, P. (2015). Equations basées sur la créatinine pour l’adaptation posologique des médicaments dans une population de patients obèses [Poster presentation]. XVII réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Lyon, France. |
BOUQUEGNEAU, A., Vidal-Petiot, E., Vrtovsnik, F., CAVALIER, E., KRZESINSKI, J.-M., Flamant, M., & DELANAYE, P. (2014). Accuracy of Cockcroft&Gault and CKD-EPI equations to estimate glomerular filtration rate in obese population [Poster presentation]. LI Congress of ERA-EDTA, Amsterdam, Netherlands. |
BOUQUEGNEAU, A., Vidal-Petito, E., Vrtovsnik, F., CAVALIER, E., KRZESINSKI, J.-M., Flamant, M., & DELANAYE, P. (2014). Cockcroft&Gault and CKD-EPI equations: are these equations concordant to adjust drug dosage? [Poster presentation]. LI Congress of ERA-EDTA, Amsterdam, Netherlands. |
BOUQUEGNEAU, A., Vidal-Petiot, E., Vrtovsnik, F., CAVALIER, E., RORIVE, M., KRZESINSKI, J.-M., DELANAYE, P., & Flamant, M. (November 2013). Modification of diet in renal disease versus chronic kidney disease epidemiology collaboration equation to estimate glomerular filtration rate in obese patients. Nephrology Dialysis Transplantation, 28 (4), 122-130. doi:10.1093/ndt/gft329 |
BOUQUEGNEAU, A., CAVALIER, E., Krzesinski, J.-M., & DELANAYE, P. (18 April 2013). MDRD VERSUS CKD-EPI EQUATIONS TO ESTIMATE GLOMERULAR FILTRATION RATE IN OBESE PATIENTS [Poster presentation]. 50th ERA-EDTA Congress, Istanbul, Turkey. |
Benoit, A., BOUQUEGNEAU, A., PETROSSIANS, P., & Beckers, A. (2013). Malabsorption des hormones thyroïdiennes... ou simple manque de compliance ? Revue Médicale de Liège, 68 (3), 118-121. |
BOUQUEGNEAU, A., DELANAYE, P., CAVALIER, E., & Krzesinski, J.-M. (2013). Annual meeting of the SBN/BVN [Paper presentation]. Annual meeting of the SBN/BVN, Bruxelles, Belgium. |
DELANAYE, P., Vidal-Patiot, E., BOUQUEGNEAU, A., Vrtovsnik, F., CAVALIER, E., KRZESINSKI, J.-M., & Flamant, M. (2013). MDRD versus CKD-EPI equations to estimate glomerular filtration rate in obese patients [Poster presentation]. ASN Kidney Week, Atlanta, United States - Georgia. |
Vidal-Petiot, E., DELANAYE, P., BOUQUEGNEAU, A., Vrtovsnik, F., CAVALIER, E., & Flamant, M. (2013). Estimation du débit de filtration glomérulaire chez l’obèse : MDRD ou CKD-EPI ? [Poster presentation]. XV réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Nantes, France. |
BOUQUEGNEAU, A., DUBOIS, B., Krzesinski, J.-M., & DELANAYE, P. (2012). Anorexia Nervosa and the Kidney. American Journal of Kidney Diseases, 60 (2), 299-307. doi:10.1053/j.ajkd.2012.03.019 |
DELANAYE, P., BOUQUEGNEAU, A., DUBOIS, B., & ANDRE, B. (2012). Le médicament du mois : Fébuxostat (Adenuric®). Revue Médicale de Liège, 67 (4), 202-209. |
BOUQUEGNEAU, A., Longton, J., Bovy, C., & Krzesinski, J.-M. (2010). La néphropathie tubulo-interstitielle aiguë: une cause rare d’insuffisance rénale aiguë. Revue Médicale de Liège, 65 (7-8), 459-463. |